Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Biotechnology

Ardelyx, Inc. manufactures biotechnological drugs. The Company offers pharmaceuticals to correct mineral metabolism imbalance and metabolic disorders by modulating the function of specific transporters, channels, and receptors located on the epithelia of the gastrointestinal tract. Ardelyx serves patients in the United States.
Website: ardelyx.com


  • Good financial results growth rate 100.0% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (80.2%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield -4.5% (LTM)
  • Share price is 171.8% higher than minimum and 19.9% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (500.0x vs 30.0x)
  • For the last 3 months insiders sold company shares on $0.8 mln (-0.081% of cap.)

Key Financials (Download financials)

Ticker: ARDX
Share price, USD:  (0.0%)7.8
year average price 5.34  


year start price 5.79 2025-02-14

min close price 3.28 2025-05-14

max close price 7.99 2026-01-21

current price 7.80 2026-02-14
Common stocks: 163 088 367

Dividend Yield:  0.0%
EV / Sales: 2.5x
Margin (EBITDA LTM / Revenue): -8.5%

Target EV / EBITDA (hist percentile): 30.0x
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 1 272
Net Debt ($m): 89
EV (Enterprise Value): 1 361
EBITDA LTM (млн $): -47
Price to Book: 8.2x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-01-21seekingalpha.com

Ardelyx: Assessment Of Acquisition Rumors

2026-01-21zacks.com

Strength Seen in Ardelyx (ARDX): Can Its 15.0% Jump Turn into More Strength?

2026-01-12zacks.com

Are Medical Stocks Lagging Ardelyx (ARDX) This Year?

2025-11-05seekingalpha.com

Ardelyx: Impressive Q3 Record Growth - Why I Buy

2025-11-04seekingalpha.com

Ardelyx: A Long Overdue Rally

2025-10-30seekingalpha.com

Ardelyx, Inc. (ARDX) Q3 2025 Earnings Call Transcript

2025-10-30zacks.com

Ardelyx (ARDX) Reports Break-Even Earnings for Q3

2025-10-13globenewswire.com

Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025

2025-09-08seekingalpha.com

Ardelyx, Inc. (ARDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

2025-09-03seekingalpha.com

Ardelyx, Inc. (ARDX) Presents At Citi's Biopharma Back To School Conference Transcript
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-30 2025-08-04 2024-10-31 2024-08-01 2024-05-02 2023-10-31 2023-08-02 2023-05-03 2022-11-03
acceptedDate 2025-10-30 16:16:56 2025-08-04 16:41:51 2025-02-20 12:08:28 2024-10-31 16:06:05 2024-08-01 16:05:38 2024-05-02 16:05:25 2024-02-22 16:40:06 2023-10-31 07:03:07 2023-08-02 07:02:50 2023-05-03 16:07:02 2023-03-02 16:05:56 2022-11-03 16:08:35 2022-02-28 16:05:54 2021-03-08 08:14:57
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 110M 98M 334M 98M 73M 46M 124M 56M 22M 11M 52M 5M 10M 8M
costOfRevenue 1M 12M 51M 16M 10M 8M 18M 7M 3M 2M 4M 732 000 1 000 000 145 000
grossProfit 109M 85M 283M 83M 63M 38M 107M 49M 19M 10M 48M 4M 9M 7M
grossProfitRatio 0.988 0.873 0.84 0.863 0.836 0.875 0.844 0.865 0.853
researchAndDevelopmentExpenses 18M 16M 52M 15M 12M 10M 36M 9M 8M 9M 35M 7M 91M 65M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 77M 19M 72M 33M
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 84M 84M 259M 65M 65M 53M 134M 33M 27M 27M 77M 19M 72M 33M
otherExpenses 3M 0 0 0 2M 2M 0 1M 2M 1M 0 0 0 0
operatingExpenses 104M 100M 311M 80M 77M 63M 170M 41M 35M 36M 112M 26M 163M 98M
costAndExpenses 106M 112M 362M 96M 87M 71M 188M 48M 39M 37M 116M 27M 164M 98M
interestIncome 0 0 0 0 0 0 0 2M 0 0 0 0 0 0
interestExpense 6M 7M 20M 5M 5M 4M 9M -1M 2M 2M 5M 2M 5M 5M
depreciationAndAmortization 905 000 631 000 2M 544 000 569 000 435 000 1M 291 000 642 000 1M 1M 1M 3M 4M
ebitda 6M -12M -17M 5M -11M -24M -55M 7M -14M -25M -61M -21M -151M -85M
ebitdaratio 0.053 -0.122 0.051 -0.178 -0.527 0.131 -0.646 -2.178 -4.121
operatingIncome 5M -14M -28M 2M -14M -25M -63M 7M -17M -26M -64M -22M -154M -91M
operatingIncomeRatio 0.042 -0.147 0.023 -0.186 -0.536 0.131 -0.744 -2.293 -4.388
totalOtherIncomeExpensesNet -6M -5M -11M -3M -3M -2M -2M -569 000 2M -695 000 -3M -1M -4M -4M
incomeBeforeTax -867 000 -19M -39M -766 000 -16M -26M -66M 7M -17M -27M -67M -23M -158M -94M
incomeBeforeTaxRatio -0.008 -0.195 -0.008 -0.224 -0.574 0.121 -0.767 -2.354 -4.591
incomeTaxExpense 102 000 1000 266 000 43 000 67 000 121 000 547 000 200 000 4M 14 000 8000 1M 4000 2000
netIncome -969 000 -19M -39M -809 000 -16M -27M -66M 7M -17M -27M -67M -24M -158M -94M
netIncomeRatio -0.009 -0.195 -0.008 -0.225 -0.576 0.118 -0.767 -2.355 -4.795
eps -0.004 -0.08 -0.17 -0.003 -0.07 -0.11 -0.3 0.03 -0.08 -0.13 -0.42 -0.14 -1.52 -1.05
epsdiluted -0.004 -0.08 -0.003 -0.07 -0.11 0.029 -0.08 -0.13 -0.14
weightedAverageShsOut 242M 240M 235M 236M 235M 233M 219M 223M 215M 207M 159M 165M 104M 90M
weightedAverageShsOutDil 242M 240M 235M 236M 235M 233M 219M 228M 215M 207M 159M 165M 104M 90M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-20 2024-02-22 2023-03-02 2022-02-28 2021-03-08
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -20M -9M -5M -5M -5M
ebit -19M -57M -62M -154M -89M
nonOperatingIncomeExcludingInterest -9M -7M -2M -687 000 -2M
netIncomeFromContinuingOperations -39M -66M -67M -158M -94M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -39M -66M -67M -158M -94M
epsDiluted -0.17 -0.3 -0.42 -1.52 -1.05

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-30 2025-08-04 2024-10-31 2024-08-01 2024-05-02 2023-10-31 2023-08-02 2023-05-03 2022-11-03
acceptedDate 2025-10-30 16:16:56 2025-08-04 16:41:51 2025-02-20 12:08:28 2024-10-31 16:06:05 2024-08-01 16:05:38 2024-05-02 16:05:25 2024-02-22 16:40:06 2023-10-31 07:03:07 2023-08-02 07:02:50 2023-05-03 16:07:02 2023-03-02 16:05:56 2022-11-03 16:08:35 2022-02-28 16:05:54 2021-03-08 08:14:57
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 43M 90M 65M 47M 42M 36M 21M 34M 30M 92M 96M 62M 72M 91M
shortTermInvestments 200M 148M 185M 143M 144M 166M 163M 131M 98M 38M 28M 29M 44M 95M
cashAndShortTermInvestments 243M 238M 250M 190M 186M 203M 184M 165M 128M 130M 124M 91M 117M 186M
netReceivables 77M 63M 58M 53M 37M 28M 22M 43M 9M 12M 8M 5M 502 000 0
inventory 25M 22M 21M 11M 14M 10M 12M 9M 8M 5M 3M 1M 0 0
otherCurrentAssets 23M 28M 11M 29M 26M 17M 8M 7M 5M 6M 5M 23M 1 0
totalCurrentAssets 368M 352M 356M 284M 263M 258M 246M 241M 162M 167M 154M 120M 134M 195M
propertyPlantEquipmentNet 7M 7M 4M 5M 5M 6M 7M 8M 8M 9M 11M 11M 15M 4M
goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
goodwillAndIntangibleAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
longTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 2M
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 111M 108M 75M 79M 75M 79M 45M 41M 41M 41M 26M 13M 1M 0
totalNonCurrentAssets 118M 115M 79M 84M 80M 84M 51M 48M 49M 50M 36M 25M 16M 6M
otherAssets 0 0 0 0 1 1 0 0 0 0 0 0 0 0
totalAssets 486M 467M 436M 368M 343M 342M 298M 289M 211M 217M 190M 145M 150M 202M
accountPayables 18M 22M 16M 16M 11M 17M 11M 8M 5M 11M 11M 3M 4M 6M
shortTermDebt 1M 1M 0 5M 7M 4M 0 4M 31M 31M 27M 30M 32M 6M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 7M 6M 11M 7M 11M 7M 7M 4M 6M 6M 4M 4M 0 4M
otherCurrentLiabilities 57M 53M 50M 42M 34M 29M 15M 27M 19M 16M 10M 15M 1M 5M
totalCurrentLiabilities 83M 82M 78M 70M 62M 57M 50M 44M 62M 63M 66M 52M 53M 28M
longTermDebt 206M 205M 151M 102M 101M 100M 50M 30M 4M 5M 0 7M 0 47M
deferredRevenueNonCurrent 14M 12M 7M 13M 33M 34M 9M 10M 9M 11M 9M 9M 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 -22M -34M 0 14M 13M 0 0 0 0 0
otherNonCurrentLiabilities 29M 28M 26M 24M 23M 35M 20M 170 000 172 000 12M 11M -12M 5M 0
totalNonCurrentLiabilities 249M 246M 185M 139M 134M 135M 80M 55M 26M 29M 26M 26M 14M 47M
otherLiabilities 0 0 0 0 1 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 5M 5M 3M 4M 5M 778 000 6M 7M 8M 9M 10M 11M 13M 3M
totalLiabilities 332M 327M 262M 210M 196M 191M 131M 98M 88M 92M 92M 78M 67M 75M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 24 000 24 000 24 000 24 000 23 000 23 000 23 000 23 000 22 000 21 000 20 000 19 000 13 000 9000
retainedEarnings -947M -946M -885M -890M -889M -873M -846M -817M -824M -807M -780M -791M -713M -555M
accumulatedOtherComprehensiveIncomeLoss 124 000 -38 000 57 000 185 000 -101 000 -20 000 224 000 -201 000 -210 000 -20 000 -54 000 -114 000 -6000 -4000
othertotalStockholdersEquity 1 101M 1 085M 1 048M 1 036M 1 024M 1 009M 947M 932M 858M
totalStockholdersEquity 154M 140M 173M 158M 147M 151M 167M 191M 123M 125M 98M 67M 83M 126M
totalEquity 154M 140M 173M 158M 147M 151M 167M 191M 123M 125M 98M 67M 83M 126M
totalLiabilitiesAndStockholdersEquity 486M 467M 368M 343M 342M 289M 211M 217M 145M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 486M 467M 436M 368M 343M 342M 298M 289M 211M 217M 190M 145M 150M 202M
totalInvestments 200M 148M 185M 143M 144M 166M 163M 131M 98M 38M 28M 29M 44M 98M
totalDebt 208M 207M 153M 104M 105M 105M 56M 34M 35M 36M 36M 37M 46M 55M
netDebt 165M 117M 89M 57M 63M 69M 35M 670 000 5M -57M -60M -24M -27M -36M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-20 2024-02-22 2023-03-02 2022-02-28 2021-03-08
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 58M 22M 8M 502 000 0
otherReceivables 0 0 0 0 0
prepaids 16M 19M 14M 16M 8M
totalPayables 16M 11M 11M 4M 6M
otherPayables 0 0 0 0 0
accruedExpenses 0 13M 10M 12M 5M
capitalLeaseObligationsCurrent 2M 4M 4M 3M 2M
capitalLeaseObligationsNonCurrent 1M 2M 6M 10M 413 000
treasuryStock 0 0 0 0 0
additionalPaidInCapital 1 059M 1 013M 879M 796M 681M
otherTotalStockholdersEquity 0 0 0 -0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX ARDX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-30 2025-08-04 2024-10-31 2024-08-01 2024-05-02 2023-10-31 2023-08-02 2023-05-03 2022-11-03
acceptedDate 2025-10-30 16:16:56 2025-08-04 16:41:51 2025-02-20 12:08:28 2024-10-31 16:06:05 2024-08-01 16:05:38 2024-05-02 16:05:25 2024-02-22 16:40:06 2023-10-31 07:03:07 2023-08-02 07:02:50 2023-05-03 16:07:02 2023-03-02 16:05:56 2022-11-03 16:08:35 2022-02-28 16:05:54 2021-03-08 08:14:57
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -969 000 -19M -39M -809 000 -16M -27M -66M 7M -17M -27M -67M -23M -158M -94M
depreciationAndAmortization 905 000 631 000 2M 544 000 569 000 435 000 1M 291 000 642 000 -3000 1M 628 000 1M 2M
deferredIncomeTax 0 0 0 0 0 0 0 0 -499 000 0 0 0 -190 000 315 000
stockBasedCompensation 13M 12M 37M 9M 11M 8M 14M 3M 3M 3M 11M 2M 12M 11M
changeInWorkingCapital -9M -19M -49M 33M -15M -19M -43M -33M -2M -23M -20M -6M -12M -3M
accountsReceivables -14M -16M -36M -16M -9M -6M -14M -34M 3M -4M -7M 415 000 -502 000 750 000
inventory -6M -17M -42M -2M -5M -29M -21M 414 000 -3M -17M -28M -5M -10M -750 000
accountsPayables -3M 8M 5M 4M -6M 6M 279 000 2M -5M -346 000 7M -1M -1M 3M
otherWorkingCapital 14M 7M 23M 47M 5M 11M -8M -1M 3M -2M 9M -57 000 300 000 -7M
otherNonCashItems -3M 348 000 4M -42M 32M 39M 5M 910 000 1M 2M 5M 1M 4M 3M
netCashProvidedByOperatingActivities 365 000 -25M -45M 501 000 -19M -36M -90M -21M -15M -45M -70M -25M -153M -81M
investmentsInPropertyPlantAndEquipment -156 000 -650 000 -1M -137 000 -131 000 -150 000 -344 000 -194 000 -93 000 -14 000 -55 000 0 -2M -324 000
acquisitionsNet 0 0 0 0 0 0 0 33M 0 0 0 0 -53M 31M
purchasesOfInvestments -114M -23M -195M -40M -23M -34M -215M -50M -67M -21M -50M -18M -73M -151M
salesMaturitiesOfInvestments 63M 58M 178M 42M 47M 32M 84M 17M 8M 11M 67M 17M 126M 120M
otherInvestingActivites 0 0 0 24M -2M -33M 0 0 530 000
netCashUsedForInvestingActivites -51M 35M 2M 24M -3M -33M -59M -10M -832 000
debtRepayment 0 49M 0 0 -50M 0 0 0 0
commonStockIssued 0 988 000 3M 2M 3M 57M 11M 51M 34M
commonStockRepurchased 0 0 0 0 0 3M 0 670 000 0 200 000 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites 3M 0 0 2M 50M -58M 149 000 0 112 000
netCashUsedProvidedByFinancingActivities 3M 50M 3M 2M 53M 58M 12M 51M 34M
effectOfForexChangesOnCash 0 0 0 0 0 0 0 64M 149M 0 0 0 0 0
netChangeInCash -47M 59M 43M 6M 6M 15M -75M 4M -62M -4M 24M 8M -19M -90M
cashAtEndOfPeriod 43M 90M 65M 47M 42M 36M 21M 34M 30M 92M 96M 62M 72M 91M
cashAtBeginningOfPeriod 90M 31M 21M 42M 36M 21M 96M 30M 92M 96M 72M 53M 91M 181M
operatingCashFlow 365 000 -25M -45M 501 000 -19M -36M -90M -21M -15M -45M -70M -25M -153M -81M
capitalExpenditure -156 000 -650 000 -1M -137 000 -131 000 -150 000 -344 000 -194 000 -93 000 -14 000 -55 000 0 -2M -324 000
freeCashFlow 209 000 -26M -46M 364 000 -20M -36M -90M -22M -15M -45M -70M -25M -154M -82M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-20 2024-02-22 2023-03-02 2022-02-28 2021-03-08
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 2M 53M -31M
netCashProvidedByInvestingActivities -18M -131M 18M 51M -31M
netDebtIssuance 99M 22M -6M -19M -125 000
longTermNetDebtIssuance 99M 22M -6M -19M -125 000
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 8M 119M 72M 101M 21M
netCommonStockIssuance 8M 119M 72M 101M 21M
commonStockIssuance 8M 119M 72M 101M 21M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -1 000 000 5M 10M 1M 2M
netCashProvidedByFinancingActivities 107M 146M 75M 83M 23M
incomeTaxesPaid 266 000 51 000 6000 4000 1000
interestPaid 11M 4M 3M 3M 4M

Earning call transcript

2025 q3
2025-10-30 ET (fiscal 2025 q3)
2025 q2
2025-08-04 ET (fiscal 2025 q2)
2025 q1
2025-05-01 ET (fiscal 2025 q1)
2024 q4
2025-02-20 ET (fiscal 2024 q4)
2024 q3
2024-10-31 ET (fiscal 2024 q3)
2024 q2
2024-08-01 ET (fiscal 2024 q2)
2024 q1
2024-05-02 ET (fiscal 2024 q1)
2023 q4
2024-02-22 ET (fiscal 2023 q4)
2023 q3
2023-10-31 ET (fiscal 2023 q3)
2023 q2
2023-08-02 ET (fiscal 2023 q2)
2023 q1
2023-05-03 ET (fiscal 2023 q1)
2022 q4
2023-03-02 ET (fiscal 2022 q4)
2022 q3
2022-11-06 ET (fiscal 2022 q3)
2022 q2
2022-08-07 ET (fiscal 2022 q2)
2022 q1
2022-05-05 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2026-01-08 13:34 ET
Ardelyx published news for 2025 q4
SEC form 10
2025-10-30 20:16 ET
Ardelyx reported for 2025 q3
SEC form 8
2025-10-30 20:09 ET
Ardelyx reported for 2025 q3
SEC form 8
2025-10-30 20:09 ET
Ardelyx published news for 2025 q3
SEC form 10
2025-08-04 20:41 ET
Ardelyx reported for 2025 q2
SEC form 8
2025-08-04 20:22 ET
Ardelyx published news for 2025 q2
SEC form 8
2025-08-04 20:22 ET
Ardelyx published news for 2025 q2
SEC form 8
2025-08-04 20:22 ET
Ardelyx reported for 2025 q2
SEC form 8
2025-07-03 12:49 ET
Ardelyx published news for 2025 q2
SEC form 8
2025-07-03 12:49 ET
Ardelyx published news for 2025 q2
SEC form 10
2025-05-01 20:04 ET
Ardelyx published news for 2025 q1
SEC form 8
2025-05-01 20:03 ET
Ardelyx published news for 2025 q1
SEC form 8
2025-05-01 20:03 ET
Ardelyx reported for 2025 q1
SEC form 10
2025-05-01 00:00 ET
Ardelyx published news for 2025 q1
SEC form 10
2025-02-20 12:08 ET
Ardelyx published news for 2024 q4
SEC form 8
2025-02-20 07:34 ET
Ardelyx published news for 2024 q4
SEC form 8
2025-02-20 07:34 ET
Ardelyx reported for 2024 q4
SEC form 10
2025-02-20 00:00 ET
Ardelyx published news for 2024 q4
SEC form 8
2025-01-13 00:00 ET
Ardelyx published news for 2024 q4
SEC form 10
2024-10-31 16:06 ET
Ardelyx reported for 2024 q3
SEC form 8
2024-10-31 16:04 ET
Ardelyx reported for 2024 q3
SEC form 8
2024-10-31 16:04 ET
Ardelyx published news for 2024 q3
SEC form 10
2024-08-01 16:05 ET
Ardelyx reported for 2024 q2
SEC form 8
2024-08-01 16:03 ET
Ardelyx reported for 2024 q2
SEC form 8
2024-08-01 16:03 ET
Ardelyx published news for 2024 q2
SEC form 10
2024-08-01 00:00 ET
Ardelyx reported for 2024 q2
SEC form 10
2024-05-02 16:05 ET
Ardelyx published news for 2024 q1
SEC form 8
2024-05-02 16:04 ET
Ardelyx reported for 2024 q1
SEC form 8
2024-05-02 16:04 ET
Ardelyx published news for 2024 q1
SEC form 10
2024-05-02 00:00 ET
Ardelyx published news for 2024 q1
SEC form 10
2024-02-22 16:40 ET
Ardelyx published news for 2023 q4
SEC form 8
2024-02-22 16:04 ET
Ardelyx published news for 2023 q4
SEC form 8
2024-02-22 16:04 ET
Ardelyx reported for 2023 q4
SEC form 10
2024-02-22 00:00 ET
Ardelyx published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Ardelyx published news for 2023 q4
SEC form 10
2023-10-31 07:03 ET
Ardelyx reported for 2023 q3
SEC form 8
2023-10-31 07:02 ET
Ardelyx reported for 2023 q3
SEC form 10
2023-10-31 00:00 ET
Ardelyx reported for 2023 q3
SEC form 10
2023-08-02 07:02 ET
Ardelyx reported for 2023 q2
SEC form 6
2023-08-02 07:01 ET
Ardelyx reported for 2023 q2
SEC form 8
2023-08-02 00:00 ET
Ardelyx reported for 2023 q2
SEC form 10
2023-08-02 00:00 ET
Ardelyx reported for 2023 q2
SEC form 6
2023-06-20 16:05 ET
Ardelyx published news for 2023 q1
SEC form 8
2023-05-03 00:00 ET
Ardelyx reported for 2023 q1
SEC form 10
2023-05-03 00:00 ET
Ardelyx reported for 2023 q1
SEC form 6
2023-04-26 16:15 ET
Ardelyx published news for 2023 q1
SEC form 6
2023-04-14 16:17 ET
Ardelyx published news for 2023 q1
SEC form 8
2023-03-02 00:00 ET
Ardelyx reported for 2022 q4
SEC form 10
2023-03-02 00:00 ET
Ardelyx reported for 2022 q4
SEC form 10
2022-11-03 00:00 ET
Ardelyx reported for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Ardelyx reported for 2022 q3
SEC form 8
2022-08-04 00:00 ET
Ardelyx reported for 2022 q2
SEC form 10
2022-08-04 00:00 ET
Ardelyx reported for 2022 q2
SEC form 8
2022-05-05 00:00 ET
Ardelyx reported for 2022 q1
SEC form 10
2022-05-05 00:00 ET
Ardelyx reported for 2022 q1
SEC form 8
2022-02-28 00:00 ET
Ardelyx published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
Ardelyx published news for 2021 q4
SEC form 8
2021-11-12 00:00 ET
Ardelyx published news for 2021 q3
SEC form 10
2021-11-12 00:00 ET
Ardelyx published news for 2021 q3
SEC form 8
2021-08-13 00:00 ET
Ardelyx published news for 2021 q2
SEC form 10
2021-08-13 00:00 ET
Ardelyx published news for 2021 q2
SEC form 8
2021-07-19 00:00 ET
Ardelyx published news for 2021 q2
SEC form 8
2021-05-06 00:00 ET
Ardelyx published news for 2021 q1
SEC form 10
2021-05-06 00:00 ET
Ardelyx published news for 2021 q1